X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

New Report: More than 160 medicines in development for mental illness

By Matthew Norawong  |    January 26, 2023
Mental illness represents a broad spectrum of health conditions affecting mood, thinking and behavior. These conditions include depression, bipolar disorder, schizophrenia, substance use disorder,...   Read More

New paper: Addressing the growing crisis of mental health and substance use disorders

By Lindsey Seidlitz  |    November 7, 2022
The United States is facing a crisis of mental health and addiction that has left few Americans and families unimpacted by these illnesses and the devastating consequences that are often associated...   Read More

Mental Illness Awareness Week – A time for reflection

By Andrew Powaleny  |    October 3, 2022
Each first week of October, Americans all across the country take time to reflect on an issue which is increasingly recognized as impacting everyone, whether it be directly as it does me, or...   Read More

Spotlighting a growing mental health challenge

By Anne McDonald Pritchett, PhD  |    May 9, 2022
During the pandemic, about four in 10 American adults have reported symptoms of anxiety or depressive disorder. This share is up from one in 10 adults reporting symptoms prior to the pandemic....   Read More

A conversation with Barry Greene, CEO of Sage Therapeutics

By Stephen J. Ubl  |    May 4, 2022
Our industry continues working to build a more resilient, affordable and equitable health care system. As part of Mental Health Awareness Month, I recently had the opportunity to connect with PhRMA...   Read More

Guest post: Joining forces to combat the COVID-19 mental health crisis

By Guest Contributor  |    February 17, 2022
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...   Read More

Guest Blog: COVID-19 vaccines are the key to keeping kids healthy

By Guest Contributor  |    February 16, 2022
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest...   Read More

Coming together to fight COVID-19: A conversation with Barry Greene, CEO of Sage Therapeutics

By Stephen J. Ubl  |    June 9, 2021
This year, our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. A key...   Read More

Reflecting on Mental Health Awareness Month

By Andrew Powaleny  |    May 4, 2021
As communities around the world continue to grapple with the impact of COVID-19, the importance of furthering our understanding of the impact on our mental health is undeniable.   Read More

Action needed to preserve the six protected classes

By Tom Wilbur  |    February 3, 2021
In the final hours of the previous Administration’s time in office, the Center for Medicare & Medicaid Innovation (the Innovation Center) (CMMI) announced new changes for CY 2022 to an existing...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."